The primary objective of this study was to determine the prevalence of GPVs in BRCA1, BRCA2, and PALB2 (B1B2P2) as well as in other breast cancer susceptibility genes (BCSGs) within a racially and ethnically diverse cohort of women with newly diagnosed breast cancer. This evidence concerns the gene PALB2 and breast carcinoma.